Bing

SEARCH HISTORY

Antares Pharma Inc (NASDAQ:ATRS) stock fell by 7% on Wednesday to $2.14 after it issued the pricing of its follow on offering to raise additional capital. Antares Pharma will issue another 20 million shares of common stock at $2.00 per share raising $37 ...
GDP Insider · 5/7/2015
Stock analysts at Piper Jaffray assumed coverage on shares of Antares Pharma (NASDAQ:ATRS) in a report issued on Monday, TheFlyOnTheWall.com reports. The firm set an “overweight” rating and a $3.50 price target on the stock. Piper Jaffray’s …
Mideast Times · 5/19/2015
Atrium is based in Jersey and is dual-listed on the Vienna and Euronext Amsterdam Stock Exchanges under the ticker ATRS. Atrium is established as a closed-end investment company incorporated and domiciled in Jersey and regulated by the Jersey …
4 Traders · 6/24/2015
More from Bing News
stock to profit in the near future. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >> Get the latest research report on ATRS - FREE
ZACKS · 6/8/2015
Antares Pharma Inc. ( ATRS) is a company in the Medical/Dental Supplier space that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings ...
NASDAQ · 6/8/2015
By October of last year, Antares Pharma shares had made a 30% advance (from April of that year) as traders were jockeying to get into the stock before the October 14th PDUFA date for injectable Otrexup, for arthritis and psoriasis. ATRS shares gained ...
Smallcap Network · ByBryan Murphy · 6/12/2014
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies ... http://investorplace.com/2014/12/3-medical-devices-stocks-to-buy-now-wwin-atrs-mdt-32/.
Investor Place · 12/1/2014
Antares Pharma Inc. (ATRS) has offered to sell 20 million shares of its common stock to the public at a price of $2.00 each. The underwriters have a 30-day option to purchase up to 3 million additional shares of common stock. The net proceeds from this ...
Realtime Business News · 5/7/2015
Before the current sale, Deerfield boosted its stake in Antares Pharma Inc (NASDAQ:ATRS) during May by some 9.50 million shares. So far this year the stock of the $365.74 million specialty pharmaceutical company has declined by 6.22% while the …
INSIDER MONKEY · 6/17/2015
ADVISORY, Feb 19, 2014 (GLOBE NEWSWIRE via COMTEX) -- What: Antares Pharma, Inc. [ATRS], a revenue-generating product focused specialty pharmaceutical company that has developed three proprietary platforms, will visit the NASDAQ MarketSite …
Market Watch · 2/19/2014